Valganciclovir FDA Link

A ganciclovir prodrug and antiviral agent that is used to treat CYTOMEGALOVIRUS RETINITIS in patients with AIDS, and for the prevention of CYTOMEGALOVIRUS INFECTIONS in organ transplant recipients who have received an organ from a CMV-positive donor.

Also Known As:

Ganciclovir L-valyl Ester; Valcyt; Valcyte; Valganciclovir Hydrochloride; Ganciclovir L valyl Ester; L-Valine, 2- ((2- amino- 3,6- dihydro- 6- oxo- 9H- purin- 9- yl)methoxy)- 3- hydroxypropyl ester

Heterocyclic Compounds: 207
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Purines: 664
      - Purinones: 2
        Hypoxanthines: 1
        Guanine: 1826
        Acyclovir: 4866
        Ganciclovir: 3815
        Valganciclovir: 679

Justina Magallhaes Selected Research

Justina Magallhaes Research Topics

Disease

Drug/Important Bio-Agent (IBA)